A Retrospective Chart Review Study to Evaluate Safety of McGhan Single Lumen Gel-Filled Breast Implants in Patients in China

Sponsor
Allergan (Industry)
Overall Status
Completed
CT.gov ID
NCT04261608
Collaborator
(none)
225
6
3.1
37.5
12.3

Study Details

Study Description

Brief Summary

This study is a retrospective chart review and entails review of medical records of patients enrolled in about 5 hospitals/clinics in China, and who have undergone breast augmentation or reconstruction with McGhan breast implants between 24 December 2015 and 31 December 2019. The safety of McGhan breast implants (textured and smooth) will be evaluated based on occurrence of local complications including capsular contracture, malposition of implant, seroma/late seroma and anaplastic large cell lymphoma (ALCL).

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    225 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    A Retrospective Chart Review Study to Evaluate Safety of McGhan Single Lumen Gel-Filled Breast Implants in Patients in China
    Actual Study Start Date :
    Apr 2, 2020
    Actual Primary Completion Date :
    Jul 4, 2020
    Actual Study Completion Date :
    Jul 4, 2020

    Outcome Measures

    Primary Outcome Measures

    1. Number of participants who experienced adverse events [up to 4 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • patients who underwent breast augmentation or reconstruction with McGhan breast implants between 24 December 2015 and 31 December 2019
    Exclusion Criteria:

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Beijing Lidu Plastic Surgery Hospital Beijing Beijing China
    2 Plastic Surgery Hospital Chinese Academy of Medical Sciences Beijing Beijing China
    3 Guangzhou Sogood Medical Cosmetology Hospital Guangzhou Guangdong China
    4 The Second People's Hospital of Guangdong Province Guangzhou Guangdong China
    5 Changsha Yan Han Medical Plastic Hospital Changsha Hunan China
    6 Hunan Yamei Medical Cosmetology Hospital Changsha Hunan China

    Sponsors and Collaborators

    • Allergan

    Investigators

    • Principal Investigator: Jie Luan, Professor, Chinese Academy of Medical Sciences

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Allergan
    ClinicalTrials.gov Identifier:
    NCT04261608
    Other Study ID Numbers:
    • MED-EPI-PLS-0637
    First Posted:
    Feb 10, 2020
    Last Update Posted:
    Sep 21, 2020
    Last Verified:
    Sep 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Sep 21, 2020